Patients with skin cancer in England and Wales will be first in Europe to benefit from new treatment
Patients with skin cancer in England will be the first in Europe to have access to new drugs which can stall progression of advanced (unresectable or metastatic) melanoma by an average of eight months, compared with standard treatment.
Source: Care Feeds
Our Office is Open from 9 am-5 pm Mon to Fri
ICare Nottingham Ltd
172 Derby Road,
T: 0115 9782403